grant

Diabetes Genomics and Analysis Core

Organization STANFORD UNIVERSITYLocation STANFORD, UNITED STATESPosted 15 Sept 2017Deadline 30 Jun 2027
NIHUS FederalResearch GrantFY2025ATAC sequencingATAC-seqATACseqAbbreviationsAdoptionAdult-Onset Diabetes MellitusArchitectureAssayAssay for Transposase-Accessible Chromatin using sequencingAwardBioassayBioinformaticsBiologicalBiological AssayBrittle Diabetes MellitusCell NucleusChIP SequencingChIP assayChIP-seqChIPseqChromatinChromatin StructureComputational toolkitConsultationsDNA methylation profilingDataData AnalysesData AnalysisDevelopmentDiabetes MellitusEncapsulatedEngineering / ArchitectureEquipmentEvolutionGene Expression MonitoringGene Expression Pattern AnalysisGene Expression ProfilingGeneralized GrowthGeneticGenomeGenomic DNAGenomic medicineGenomicsGoalsGrowthHealthHigh-Throughput Nucleotide SequencingHigh-Throughput RNA SequencingHigh-Throughput SequencingHourHumanHuman MicrobiomeIDDMIndividualInformaticsInsulin-Dependent Diabetes MellitusInvestigatorsJuvenile-Onset Diabetes MellitusKetosis-Prone Diabetes MellitusKetosis-Resistant Diabetes MellitusLaboratoriesLibrariesMaturity-Onset Diabetes MellitusMethyl-SeqMethylSeqMethylation sequencingModern ManModernizationNGS MethodNGS systemNIDDMNon-Insulin Dependent DiabetesNon-Insulin-Dependent Diabetes MellitusNoninsulin Dependent DiabetesNoninsulin Dependent Diabetes MellitusNucleic AcidsNucleotidesNucleusPreparationRNA SeqRNA sequencingRNAseqRegulatory ElementResearchResearch DesignResearch PersonnelResearch ResourcesResearchersResourcesServicesSingle cell seqSlow-Onset Diabetes MellitusStable Diabetes MellitusStudy TypeSudden-Onset Diabetes MellitusT1 DMT1 diabetesT1DT1DMT2 DMT2DT2DMTechniquesTechnologyTissue GrowthTrainingTranscript Expression AnalysesTranscript Expression AnalysisTransposaseType 1 Diabetes MellitusType 1 diabetesType 2 Diabetes MellitusType 2 diabetesType I Diabetes MellitusType II Diabetes MellitusType II diabetesUniversitiesadult onset diabetesanalytical methodanalyze gene expressionapplied biomedical researchapplied biomedical sciencesassay for transposase accessible chromatin followed by sequencingassay for transposase accessible chromatin seqassay for transposase accessible chromatin sequencingassay for transposase-accessible chromatin with sequencingbiologicchromatin immunoprecipitationchromatin immunoprecipitation coupled with sequencingchromatin immunoprecipitation followed by sequencingchromatin immunoprecipitation with sequencingchromatin immunoprecipitation-seqchromatin immunoprecipitation-sequencingcomputational toolboxcomputational toolscomputational toolsetcomputerized toolsconsultationcostcost effectivedata interpretationdesigndesigningdevelopmentaldiabetesexperimentexperimental researchexperimental studyexperimentsgDNAgene expression analysisgene expression assaygenome medicinegenome sequencinghuman diseasehuman-associated microbiomeinnovateinnovationinnovativeinsulin dependent diabetesinsulin dependent type 1isletjuvenile diabetesjuvenile diabetes mellitusketosis prone diabetesketosis resistant diabetesmaturity onset diabetesmedical collegemedical schoolsmembernew technologynext gen sequencingnext generation sequencingnextgen sequencingnovel technologiesontogenypersonalization of treatmentpersonalized medicinepersonalized therapypersonalized treatmentportabilitypreparationsprogramsscATAC sequencingscATAC-seqscRNA sequencingscRNA-seqschool of medicinesingle cell ATAC-seqsingle cell ATAC-sequencingsingle cell Assay for Transposase Accessible Chromatin sequencingsingle cell RNA-seqsingle cell RNAseqsingle cell expression profilingsingle cell next generation sequencingsingle cell sequencingsingle cell sequencing assay for transposase accessible chromatinsingle cell transcriptomic profilingsingle-cell Assay for Transposase-Accessible Chromatin with sequencingsingle-cell RNA sequencingsingle-cell assay for transposase-accessible chromatin using sequencingsingle-cell assay for transposase-accessible chromatin-seqstudy designtooltranscriptional profilingtranscriptome sequencingtranscriptomic sequencingtype 2 DMtype I diabetestype II DMtype one diabetestype two diabetes
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

DIABETES GENOMICS AND ANALYSIS CORE (DGAC): PROJECT SUMMARY/ABSTRACT
The SDRC Diabetes Genomics and Analysis Core (DGAC) supports the genomic research of SDRC

investigators through access to next-generation sequencing and modern bioinformatics analysis. Nucleotide

sequencing has become essential for formulating and resolving crucial biological questions in many contexts,

like diabetes. This includes determining the underlying causes of human diseases to monitoring gene

expression, elucidating regulatory networks and exploring organismal diversity that may impact human health,

like human microbiomes. Researchers use this technology increasingly for an ever-broadening range of

applications to detect and characterize nucleic acid molecules (RNA and DNA). The overall goal of the DGAC

is to provide SDRC investigators with a next-generation sequencing facility composed of state-of-the-art

laboratory, computational facilities and engaged bio-informatics support. The DGAC is committed to providing

SDRC laboratories with the expertise and technical support necessary to realize the potential of next-

generation sequencing in a cost-effective manner regardless of their existing expertise in genomics. This

includes active evolution of core services, like the development of the wildly popular bio-informatics ‘Office

Hours’ and consulting services: thus, the DGAC helps SDRC members from ‘start to finish’ with their

genomics-based experiments. We will continue to offer a complete package of services ranging from study

design consultation, library preparation services, access to sequencing technologies, and analysis and

interpretation of sequencing data. SDRC laboratories can leverage the technologies and expertise of the

DGAC to overcome cost-prohibitive barriers of entry into genomics. Based on the strengths of the DGAC and

its contributions, the specific aims are to provide SDRC core users guidance with design of their next-

generation sequencing projects, access to a broad range of nucleotide library preparation services, access to

sequencing services with modern sequencing technologies, and support with data analysis and interpretation

of their sequencing projects. The proven strengths of the DGAC in these techniques will continue to provide

investigators with a unique opportunity to effectively apply powerful research approaches that would be

prohibitively difficult for individual laboratories to develop. The DGAC serves as an invaluable resource for the

SDRC, providing investigators with the next-generation sequencing expertise and training necessary to

examine the genome at a level of access and subsidized cost for SDRC members that is not achievable at

Stanford without this core. The DGAC will also serve SDRC members at UC Berkeley and UC Davis, including

those supported through the proposed Regional Pilot & Feasibility Award expansion. Based on growth of the

SDRC membership, evolution of exciting new technologies, and increasing membership demand for bio-

informatic support and analysis, we anticipate growth in use of the specialized and unique DGAC services in

the coming years.

Grant Number: 5P30DK116074-09
NIH Institute/Center: NIH

Principal Investigator: HASSAN CHAIB

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →